Cytonus Therapeutics has developed a first-in-class “biologic drone” called the Cargocyte. The Cargocyte is a platform to deliver therapeutics in a precise, controlled, safe and reproducible manner. Cytonus’ innovative approach delivers on the long sought after promises of drug delivery, to deliver the right drug at the right dose to the right tissue.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $11.7M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Creative V... | creativeve... |
| - | Endless Fr... | endlessfro... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.12.2023 | Series A | $11.7M | - |
Mentions in press and media 4
| Date | Title | Description |
| 09.01.2024 | Cytonus Therapeutics Enters Licensing Agreement with Medinno for HIEstem™, a Neuro-Regenerative Cellular Therapy | Cytonus obtains exclusive rights to Medinno’s HIEstem for the North American and MENA markets SAN DIEGO, CALIFORNIA, UNITED STATES, January 9, 2024 /EINPresswire.com/ -- Cytonus Therapeutics, Inc. (“Cytonus”) a biotherapeutic company develo... |
| 04.12.2023 | Cytonus Therapeutics garners $11.7M in Series A funding to continue development of its portfolio pipeline | - |
| 04.12.2023 | Cytonus Raises $11.7M in Series A Financing | Cytonus Therapeutics, Inc., a San Diego, CA-based biotechnology company discovering and advancing novel medicines enabled by its proprietary Cargocyte™ Drug Delivery Platform, announced the initial closing of its $11.7m Series A preferred f... |
| - | Cytonus Therapeutics | “Cytonus - Cytonus” |